Health Reform WK-EDGE 2016’s major health care, life sciences, and health reform developments
Monday, January 23, 2017

2016’s major health care, life sciences, and health reform developments

Each year, the Wolters Kluwer Health Law Editorial team revisits the major legal and regulatory developments of the past year and provides that information to readers through a series of year-in-review Strategic Perspectives published in Health Law Daily and Health Reform WK-EDGE. This Strategic Perspective lists and links to all of the 2016 year-in-review stories for easy reference.

These 12 Strategic Perspectives provide a broad overview of 2016’s impact on Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), health care compliance, health reform, and the life sciences. They also preview 2017, and provide information about what the incoming Donald J. Trump (R) Administration and the 115th Congress have pledged to do.

Health Care Compliance

Strategic Perspectives following actions taken by the HHS Office of Inspector General (OIG) and others to enforce the False Claims Act (FCA) (31 U.S.C. §3729), the Health Insurance Portability and Accountability Act of 1996 (HIPAA) (P.L. 104-191), and the Anti-Kickback Statute (AKS) (42 U.S.C. §1320a-7b) included:

Medicare and Medicaid

The following Strategic Perspectives related to Medicare and Medicaid reimbursement and litigation, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10), and administrative decisions issued by the Departmental Appeals Board (DAB) and the Provider Reimbursement Review Board (PRRB):

Health Reform

One Strategic Perspective focused on 2016’s major developments related to the Patient Protection and Affordable Care Act (ACA) (P.L. 111-148): Top 5 ACA-Related Bills, Cases, and Final Rules of 2016 (December 7, 2016).

Life Sciences

Strategic Perspectives about judicial and regulatory interpretations of the federal Food, Drug and Cosmetics Act (FDC Act) (21 U.S.C. §301 et seq.) included:

Trump Administration White Paper

The Trump Administration will likely have significant impact on several areas of law, how corporations do business, and individuals. The white paper Trump’s Win Expected to Bring Significant Legal and Regulatory Changes discusses potential changes to these areas including: Tax, Health, Life Sciences, Labor and Employment, Federal Securities, Banking and Finance, Antitrust and Competition Law, Energy and Environmental Law, Government Contracts, Employee Benefits, Payroll, and Pension and Retirement.

Read further, "Trump’s Win Expected to Bring Significant Legal and Regulatory Changes."

MainStory: StrategicPerspectives NewsFeed AccountableCareNews AccessNews AgencyNews BiologicNews BiosimilarNews ContraceptionCoverageNews DemonstrationProjectNews DrugNews EmployerMandateNews EnrollmentNews EssentialBenefitNews FoodNews FraudNews GeneralNews HealthInformationTechnologyNews HealthInsuranceExchangeNews IndividualMandateNews MedicaidNews MedicaidExpansionNews MedicarePartANews MedicarePartBNews MedicarePartCNews MedicarePartDNews PenaltyNews PremiumNews ProviderPaymentNews ProgramIntegrityNews QualityNews VBPNews

Back to Top

Interested in submitting an article?

Submit your information to us today!

Learn More
Health Reform WK-EDGE

Health Reform WK-EDGE: Breaking legal news at your fingertips

Sign up today for your free trial to this daily reporting service created by attorneys, for attorneys. Stay up to date on health reform legal matters with same-day coverage of breaking news, court decisions, legislation, and regulatory activity with easy access through email or mobile app.

Free Trial Learn More